Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of YB5 cells treated with epigenetic therapy

ABSTRACT: RNA-seq was performed after YB5 cells were treated with S2101, UNC0638, GSK343, depsipeptide alone or in combination with decitabine

ORGANISM(S): Homo sapiens

PROVIDER: GSE73966 | GEO | 2016/12/31

SECONDARY ACCESSION(S): PRJNA298594

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-seq of MCF7 cells treated with epigenetic therapy

Project description:RNA-seq was performed after MCF7 cells were treated with S2101, UNC0638, GSK343, depsipeptide alone or in combination with decitabine

2016-12-31 | GSE74036 | GEO

RNA-seq of HL60 cells treated with epigenetic therapy

Project description:RNA-seq was performed after HL60 cells were treated with S2101, UNC0638, GSK343, depsipeptide alone or in combination with decitabine

2017-02-08 | GSE78102 | GEO

RNA-seq of YB5 and MCF7 treated with different doses of decitabine

Project description:RNA-seq was performed after YB5 cells were treated with 1uM decitabine, and MCF7 cells were treated with 100nM decitabine

2017-01-31 | GSE74251 | GEO

Effect of decitabine, carboplatin and their combination on gene expression in the YB5 colon cancer cell line.

Project description:YB5 cell line is a clonal derivative of the SW48 colon cancer cell line that contains a single copy of a green fluorescent protein (GFP) reporter silenced by CpG methylation at its CMV promoter. We treated the YB5 cells with decitabine (5-aza-2’-deoxycytidine), carboplatin and the combination of decitabine plus carboplatin and analyzed the effects of the drugs on gene expression. YB5 cells in the early log phase of growth were seeded at 3.5 million in 20 ml of culture medium in 10 cm diameter tissue culture plates at day 0. The cells were treated with 20 microliters of decitabine (final concentration 25 nM), carboplatin (final concentration 20 uM) or both at days 1, 2, 3 and 4. Control cells were treated with 20 microliters of diluent (DMSO). The cells were harvested at day 6. Total RNA was extracted by TRIZOL, labeled with Cy5 (control cells) or Cy3 (treated cells) and hybridized on Agilent Whole Genome Array (G4112F). Raw data from the Agilent scanner were loess normalized using Bioconductor packages limma and agilp.

2015-09-08 | E-GEOD-66279 | biostudies-arrayexpress

Effect of decitabine, carboplatin and their combination on gene expression in the YB5 colon cancer cell line.

2015-09-08 | GSE66279 | GEO

Expression and DNA methylation of colon cancer cell lines

Project description:This SuperSeries is composed of the following subset Series: GSE34077: Colon Cancer cell line YB5 untreated cells vs YB5 treated 24h with Depsipeptide at 20 nM GSE34427: DNA methylation analysis of Colon Cancer cell line SW48 Refer to individual Series

2012-04-03 | E-GEOD-34429 | biostudies-arrayexpress

ATAC-seq of YB5 cells treated with HH1

Project description:ATAC-seq was performed after YB5 cells were treated with DMSO or HH1

2018-10-26 | GSE113608 | GEO

Colon Cancer cell line YB5 untreated cells vs YB5 treated 24h with Depsipeptide at 20 nM

Project description:Study the effect of HDACi Depsipeptide on gene expression. We combined these data with whole genome DNA methylation microarray to test the reactivation of genes that have an hypermethylated promoter region.

2012-04-04 | GSE34077 | GEO

RNA-seq of YB5 cells treated with Proscillaridin A

Project description:RNA-seq was performed after YB5 cells were treated with DAC, Proscillaridin A, or the combinatino of the two

2016-11-28 | GSE89154 | GEO

Colon Cancer cell line YB5 untreated cells vs YB5 treated 24h with Depsipeptide at 20 nM

2012-04-03 | E-GEOD-34077 | biostudies-arrayexpress